Suggestions
Jens Grueger
Director and Partner at Boston Consulting Group (BCG)
Jens Grueger, PhD
Jens Grueger, PhD is a Director and Partner at Boston Consulting Group (BCG) in Zurich, Switzerland, where he is the senior expert for pricing and market access in the life sciences.12 He is also an Affiliate Professor of Health Economics at the Comparative Health Outcomes, Economics and Policy (CHOICE) Institute at the University of Washington in Seattle.1
Grueger has been a member of the Board of Directors at the Drug Information Association (DIA) since 2023.3456 He previously served as the 2020-2021 President of ISPOR, the largest professional society for health economics and outcomes research.1
Before joining BCG in 2019, Grueger had a 25-year career in the pharmaceutical industry, leading global pricing, market access, and health policy functions at Novartis, Pfizer, and Roche.12 At Roche, he drove holistic access strategies to ensure rapid, broad, and sustainable patient access to the company's innovative offerings.2
Grueger was trained in mathematics and medicine, receiving a master's degree in medical statistics (1984) and a PhD in theoretical statistics (1986) from the Technical University of Dortmund in Germany.2 He started his professional career as a health systems researcher, consulting with governments and payers from 1986 to 1994.2
As a member of the DIA Board of Directors, Grueger helps provide strategic clarity, direction, and policy objectives to offer all stakeholders opportunities to co-create, problem-solve, and illuminate cohesive pathways to the future of global and regional life sciences developments.4
Highlights
While women deliver most of the healthcare, making up 90% of nurses and 70% of healthcare employees overall, recent research has also shown that they make decisions in a more equitable fashion to both better serve patients and foster more inclusive working environments. These decision-making behaviors include a higher affinity for collaboration, being more empathetic, and showing a higher awareness for challenges faced by others. However, women hold only 25% of senior and 5% of top healthcare positions globally. Additionally, while there is growing public awareness of health equity as a topic of concern as global inequities rise, research has been largely focused on North America, Europe and Africa. This has significant implications for how health equity in patient care is addressed in other health system decisions, especially in Asia. Women x Health Equity Conference in Asia, a joint effort of the #National University of Singapore and #Monash University Malaysia and #BCG, should serve as a unique opportunity to exchange with thought leaders across a variety of healthcare sectors in Asia, jointly discuss key emerging themes, Asia-specific factors on health equity and women's representation and the future of the role of women in our industry’s leadership, enabling equitable decision-making, and providing better healthcare for all patients. We are encouraging leaders to join this meaningful discussion. Please click here for more details (https://lnkd.in/gRu3g6Fy). Contact us if you have questions or would like to join!
As a part of our ongoing work on health equity with the BCG Henderson Institute, we embarked on various case studies to test our thinking and dive deeper into the subject matter at the Global, National and Local level. Our first case study on the global fight against HIV & AIDS was published last week on BCG.com: Locking in progress against HIV / AIDS
https://lnkd.in/enJtWA2c
